Oric Pharmaceuticals, Inc.
ORIC • NASDAQ
Oric Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jacob Chacko, with a market cap of $1.2B.
Market Cap$1.2B
Employees102.0
CEOJacob Chacko
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 4, 2026 · In 3 weeksQ1 2026
Financials
Oric Pharmaceuticals, Inc. FAQ
Common questions about Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 4, 2026.
Oric Pharmaceuticals, Inc. has approximately 102 employees.